ArticleNutrition journal2025
Omega-3 polyunsaturated fatty acids and mortality risk in depression: immune-inflammatory mediation in NHANES 1999-2018.
Article in Nutrition journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
backgroundImmune-inflammatory deregulation in depression may contribute to elevated risk of subsequent mortality. While dietary omega-3 polyunsaturated fatty acids (PUFAs), particularly eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), and docosahexaenoic acid (DHA), are known to confer neuroprotective effects for their anti-inflammatory properties, population-based evidence regarding their survival benefits and underlying mechanisms in depression remain scarce. This study aimed to investigate association between dietary omega-3 PUFAs and mortality risk in depressed individuals and identify immune-inflammatory mediation underlying mortality reductions.
methodsTotally, 6,782 depressed individuals aged 20 years and above in 10 cycles (1999–2018) of the National Health and Nutrition Examination Survey (NHANES) were analyzed. Omega-3 PUFAs intake (total and individual) was assessed through 24-hour dietary recalls. Cox proportional hazard models were used to calculated hazard ratios (HRs) and 95% confidence intervals (CIs) for morality risk across omega-3 PUFA quartiles. Quantile-based g-computation model determined individual PUFA contributions, while mediation analysis evaluated the role of Geriatric Nutritional Risk Index (GNRI) and Systemic Immune-Inflammation Index (SII) in mortality reductions.
resultsOver the follow-up period of 679,294 person years, 1,281 deaths were documented. The HRs for the highest versus lowest quartile of omega-3 PUFAs were 0.76 (95% CI: 0.62, 0.94) for total mortality, 0.72 (95% CI: 0.50, 1.02) for CVD mortality, 0.82 (95% CI: 0.50, 1.35) for cancer mortality, and 0.77 (95% CI: 0.59, 1.00) for other-cause mortality. DPA showed the strongest association (58.40% weight for total mortality reduction, P = 0.002; 59.80% for other causes, P = 0.011), while EPA contributed most to cardiovascular mortality reductions (60.4%, P = 0.046). Mediation analysis revealed GNRI accounted for 8.1% of PUFA-mortality association (10.5% for DPA), with SII mediating 6.9% of DPA-specific benefit.
conclusionHigher intake of omega-3 PUFAs, predominantly EPA and DPA, were associated with a lower mortality risk in depressed individuals, partially mediated by immune-nutritional pathways. These findings underscore omega-3 PUFAs as potential dietary adjuncts for improving survival in depression through immunomodulation. Further long-term clinical studies are warranted to validate the survival benefits of omega-3 PUFAs in patients with depression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.